Medicinal plants use as an anti-inflammatory agent: a brief review on molecular pharmacological approach

Kishor  Kumar Roy; Dibyendu  Shil; Rasamalla  Mounika; Md  Masud Reja; Subhasish  Saha; Ranjan  Kumar Maji

doi:10.18231/j.joapr.2022.10.4.38.45

Authors

Kishor Kumar Roy Vaagevi Institute of Pharmaceutical Science, Warangal, Telengana https://orcid.org/0000-0003-2880-4628
Dibyendu Shil Mata Gujri College of Pharmacy, Purabpali Road, Kishanganj, Bihar
Rasamalla Mounika Vaagevi Institute of Pharmaceutical Science, Warangal, Telengana
Md Masud Reja Mata Gujri College of Pharmacy, Purabpali Road, Kishanganj, Bihar
Subhasish Saha Mata Gujri College of Pharmacy, Purabpali Road, Kishanganj, Bihar
Ranjan Kumar Maji Seemanta Institute of Pharmaceutical Science, Mayurbhanj, Odisha

DOI:

https://doi.org/10.18231/j.joapr.2022.10.4.38.45

Keywords:

Camellia sinensis, Curcuma longa, Phytopharmaceuticals, Inflammation, Mechanism of action

Abstract

Inflammation is a vital therapeutic target for creating new methods for pharmacological interventions, aside from being a stage in the pathophysiology of many diseases, such as atherosclerosis and rheumatoid arthritis. Thus, molecular understanding of inflammation has led to new opportunities for drug creation and significant new implications for current clinical medicine. It has also revealed the biological targets and mechanisms of therapeutic action, opening up new opportunities to alter complex biological systems. Meanwhile, using medicinal plants to control inflammation has been recommended as an alternative to traditional therapeutic approaches for a variety of conditions, particularly when suppression of inflammation is anticipated. Several medicinal plant species have been demonstrated to have strong anti-inflammatory properties in contemporary research. The review article was discussed about the chemical constituents and biological properties of therapeutically active plants including curcumin from Curcuma longa and epigallocatechin-3-gallate from Camellia sinensis, including the molecular pharmacology of active constituents against inflammation.

Downloads

Download data is not yet available.

References

Medzhitov, new adventures of an old flame. Cellular Inflammation, 140(6), 771-776, (2010).

Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. New England Journal of Medicine, 344(12), 907-916, (2001).

Bozkurt B, Mann DL, Deswal A. Biomarkers of inflammation in heart failure. Heart failure reviews, 15(4), 331-341, (2010).

Wiart C. Medicinal plants of Asia and the Pacific: CRC Press; 1st edition pp. 283-312, (2006).

Kawanishi S, Ohnishi S, Ma N, Hiraku Y, Murata M. Crosstalk between DNAdamage and inflammation in the multiple steps of carcinogenesis. International journal of molecular sciences, 18(8), 1808, (2017).

Pearce FL. Biological effects of histamine: an overview. Agents Actions, 33, 4-7, (1991).

Metcalfe DD, Kaliner M, Donlon MA. The mast cell. CRC Critical reviews in immunology, 3, 23-74, (1981).

Uvnas B, Aborg CH, Bergendoff A. Storage of mast cells. Evidence for an ionic binding of histamine to protein carboxyls in the granule heparin protein complex. Acta Physiolgica Scand, 336 (Suppl), 3-26, (1970).

Carswell H, Daum PR, Young JM. In: Ganellin CR, Schwartz JC, editors. Frontiers in histamine research. Histamine H1-agonist stimulated breakdown on inositol phospholipids. Oxford: Pergammon, pp. 27-38, (1985).

Uvnas B. Release process in mast cells and their activation by injury. Annals of the New York Academy of Sciences, 116, 880-890, (1964).

Dvorak AM. New aspects of mast cell biology. International Archives of Allergy and Immunology, 114, 1-9, (1997).

Pearce FL. The mast cell. Immunology and Allergy Clinics of North America, 10, 251-262, (1990).

Bhattacharyya SP, Drucker I, Reshef T, Kirshenbaum AS, Metcalfe DD, Mekori YA. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. Journal of Leukocyte Biology, 63, 337-341, (1998).

Naclerio RM, Baroody FM, Togias AG. The role of leukotrienes in allergic rhinitis: a review. American. Review of Respiralory Disease, 143, S91-95, (1991).

Ho PC, Orange RP. Indirect evidence of phospholipase an activation in purified rat mast cells during reverse anaphylactic challenge. FASEB Proc, 37, 1667, (1978).

Kennerly DA, Sullivan TJ, Sylvester P, Parker CW. Diacylglycerolmetabolism in mast cells. A potential role in membrane fusion and arachidonic acid release. Journal of Experimental Medicine, 150, 1039-1044, (1979).

Soberman RJ, Harper TW, Betteridge D, Lewis RA, Austen KF. Characterization and separation of the arachidonic acid 5-lipoxygenase and linoleic acid Ω-6 lipoxygenase (arachidonic acid 15-lipoxygenase) of human polymorphonuclear leukocytes. Journal of Biological Chemistry, 260, 4508-4515, (1985).

Rouzer CA, Matsumoto T, Samuelsson B. Single protein from human leukocytes possesses 5-lipoxygenase and leukotriene A4 synthase activities, Proceedings of the National Academy of Sciences of the United States of America, 83, 857-861, (1986).

Borgeat P, Samuelsson B. Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Journal of Biological Chemistry, 254, 2643-2646, (1979).

Corey EJ, Marfat A, Goto G, Brion F. Leukotriene B. Total synthesis and assignment of stereochemistry. Journal of the American Chemical Society, 102, 7984-7985, (1980).

Corey EJ, Clark DA, Goto G, Marfat A, Mioskowski C, Samuelsson B. Stereospecific total synthesis of a “slow reacting substance” of anaphylaxis, leukotriene C-1. Journal of the American Chemical Society, 102, 1436-1439, (1980).

Lewis RA, Holgate ST, Roberts LJ II, Oates JA, Austen KF. Preferential generation of prostaglandin D2 by rat and human mast cells. In: Becker EL, Simon AS, Austen KF, editors. Biochemistry of the acute allergic reactions. New York: Liss,; pp. 239-254, (1981.).

Schwartz L, Huff T. Biology of mast cells and basophils. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors, Allergy: principles and practice. 4th ed. St Louis (Mo): Mosby, pp.150, (1993).

Schwartz LB, Austen KF. Structure and function of the chemical mediators of mast cells. Progress in Allergy, 34, 271-321, (1984).

Hamberg M, Svensson J, Wakaboyashi T, Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proceedings of the National Academy of Sciences of the United States of America, 71, 345-349, (1974).

Proud D, Kaplan AP. Kinin formation: mechanisms and role in inflammatory disorders. Annual Review of Immunology, 6, 49-83, (1988).

Bhoola KD, Collier HOJ, Schachter M, Shorley PG. Actions of some peptides on bronchial muscle. British Journal of Pharmacology, 19, 190-197, (1962).

Keele CA. Clinical and pathological aspects of kinins in man. Proceedings of the Royal Society Biological Science, 173:361-9, (1969).

Weiss AS, Gallin JI, Kaplan AP. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. Journal of Clinical Investigation, 53, 622-33, (1974).

Colman RW, Bagdasarian A, Talamo RC, Scott CF, Seavey M, Guimaraes JA, et al. Williams Trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. Journal of Clinical Investigation, 56, 1650-1662, (1975).

Nustad K, Orstavik TB, Gautvik KM, Pierce JV. Glandular kallikreins. General Pharmacology, 9, 1-9, (1978).

Proud D, Macglashan DW Jr, Newball HH, Schulman ES, Lichenstein LM. Immunoglobulin E-mediated release of a kininogenase from purified human lung mast cells. American Review of Respiratory Disease, 132:405-408, (1985).

Newball HH, Berninger RW, Talamo RC, Lichtenstein LM. Anaphylactic release of a basophil kallikrein-like activity: purification and characterization. Journal of Clinical Investigation, 64, 457-465, (1979).

Baraniuk JN, Lundgren JD, Mizoguchi M, Peden D, Gawin A, Merida M, et al. Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo. American Review of Respiratory Disease, 141, 706-714, (1990).

Shin MH, Baroody F, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. The effect of azelastine on the early allergic response. Clinical & Experimental Allergy, 22, 289-295, (1992).

Bradding P, Holgate ST. The mast cell as a source of cytokines in asthma. Annals of the New York Academy of Sciences, 796, 272-281, (1996).

Bradding P, Feather IH, Wilson S, Holgate ST, Howarth PH. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. American Journal Respiratory and Critical Care Medicine, 151, 1900-1906, (1995).

Benson M, Strannegard IL, Wennergren G, Strannegard O. Cytokines in nasal fluids from school children with seasonal allergic rhinitis. Pediatric Allergy and Immunology, 8, 143-149, (1997).

Kim HY, Park EJ, Joe Eh, Jou I. Curcumin suppresses Janus kinase-STATinflammatory signaling through activation of Src homology 2 domain-containing tyrosinephosphatase 2 in brain microglia. The Journal of Immunology, 171(11), 6072-6079, (2003).

Natarajan C, Bright JJ. Curcumin inhibits experimental allergic encephalomyelitisby blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. The Journal of Immunology, 168(12), 6506-6513, (2002).

Xu Y, Pindolia K, Janakiraman N, Chapman R, Gautam S. Curcumin inhibits IL1alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrowbstromal cells. Hematopathology and molecular hematology, 11(1), 49-62, (1997).

Bharati AC, Panigrahi A, Sharma PK, Gupta N, Kumar R, Shukla S, Mehra NK. Clinical relevance of curcumin-induced immunosuppression in living-relateddonor renal transplant: an in vitro analysis. Experimental and Clinical Transplantation, 8(2), 161-171, (2010).

Gong Y, Xue B, Jiao J, Jing L, Wang X. Triptolide inhibits COX2 expressionand PGE2 release by suppressing the activity of NF κB and JNK in LPS treated microglia. Journal of neurochemistry, 107(3), 779-788, (2008).

Leuenroth SJ, Crews CM. Studies on calcium dependence reveal multiple modesof action for triptolide. Chemistry & biology, 12(12), 1259-1268, (2005).

Han YA, Song CW, Koh W S, Yon GH, Kim YS, Ryu SY, Lee KH. Anti-inflammatory effects of the Zingiberofficinale roscoe constituent 12-dehydrogingerdione in lipopolysaccharide-stimulated Raw 264.7 cells. Phytotherapy research: PTR, 27(8), 1200-1205, (2013).

Hussain T, Gupta S, Adhami VM, Mukhtar, H. Green tea constituent epigallocatechin 3 gallate selectively inhibits COX 2 without affecting COX 1expression in human prostate carcinoma cells. International Journal of Cancer, 113(4), 660-669, (2005).

Torres-Rodríguez ML, García-Chávez E, Berhow M, de Mejia EG. Anti-inflammatoryand anti-oxidant effect of Calea urticifolia lyophilized aqueous extract onlipopolysaccharide-stimulated RAW 264.7 macrophages. Journal of Ethnopharmacology, 188, 266-274, (2016).

Chao WW, Hong YH, Chen ML, Lin BF. Inhibitory effects of Angelica sinensis ethyl acetate extract and major compounds on NF-κB trans-activation activity andLPS-induced inflammation. Journal of Ethnopharmacology, 129(2), 244-249, (2010).

Wei WL, Zeng R, Gu CM, Qu Y, Huang LF. Angelica sinensis in China-Areview of botanical profile, ethno pharmacology, photochemistry and chemical analysis. Journal of Ethn pharmacology, 190, 116-141, (2016).

Mohri S, Takahashi H, Sakai M, Takahashi S, Waki N, Aizawa K, Shibata D. Wide-range screening of anti-inflammatory compounds in tomato using LC-MS andelucidating the mechanism of their functions. PloS one, 13(1), e0191203, (2018).

Gautam GK. A Review on the Taxonomy, Ethnobotany, Chemistry and Pharmacology of Solanum Lycopersicum Linn. International Journal of Chemistry and Pharmaceutical Sciences, 1(8), 521-527, (2013).

Ahn KS, Noh EJ, Cha KH, Kim YS, Lim SS, Shin KH, Jung SH. Inhibitory effects of Irigenin from the rhizomes of Belamcandachinensis on nitric oxideand prostaglandin E2 production in murine macrophage RAW 264.7 cells. Life sciences, 78(20), 2336-2342, (2006).

Pan CH, Kim ES, Jung SH, Nho CW, Lee JK. Tectorigenin inhibits IFN-γ/LPS-induced inflammatory responses in murine macrophage RAW 264.7 cells. Archives of pharmaceutical research, 31(11), 1447-1456, (2008).

Choi YH, Jin GY, Li GZ, Yan GH. Cornuside suppresses lipopolysaccharideinducedinflammatory mediators by inhibiting nuclear factor-kappa B activation in RAW264.7 macrophages. Biological and Pharmaceutical Bulletin, 34(7), 959-966, (2011).